Christopher R. Lines

3.2k total citations
46 papers, 2.6k citations indexed

About

Christopher R. Lines is a scholar working on Cognitive Neuroscience, Psychiatry and Mental health and Pharmacology. According to data from OpenAlex, Christopher R. Lines has authored 46 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 17 papers in Cognitive Neuroscience, 14 papers in Psychiatry and Mental health and 12 papers in Pharmacology. Recurrent topics in Christopher R. Lines's work include Trigeminal Neuralgia and Treatments (10 papers), Migraine and Headache Studies (10 papers) and Visual perception and processing mechanisms (7 papers). Christopher R. Lines is often cited by papers focused on Trigeminal Neuralgia and Treatments (10 papers), Migraine and Headache Studies (10 papers) and Visual perception and processing mechanisms (7 papers). Christopher R. Lines collaborates with scholars based in United States, United Kingdom and Spain. Christopher R. Lines's co-authors include A. David Milner, Michael D. Rugg, Gilbert Block, Michael L. Nessly, Christine Baranak, Tony W. Ho, Alan M. Rapoport, C. Assaid, Christine Furtek and Christopher J. Jones and has published in prestigious journals such as Neurology, Pain and Journal of Neurology Neurosurgery & Psychiatry.

In The Last Decade

Christopher R. Lines

45 papers receiving 2.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Christopher R. Lines United States	28	865	736	716	483	437	46	2.6k
Sophie Auriacombe France	33	1.2k 1.4×	690 0.9×	672 0.9×	191 0.4×	233 0.5×	62	2.7k
Sigrid Schuh‐Hofer Germany	23	600 0.7×	418 0.6×	642 0.9×	249 0.5×	270 0.6×	45	1.9k
Keijo Koivisto Finland	30	1.4k 1.6×	488 0.7×	1.2k 1.7×	138 0.3×	334 0.8×	63	3.4k
H.‐J. Möller Germany	27	1.0k 1.2×	671 0.9×	419 0.6×	413 0.9×	59 0.1×	55	2.6k
Péter Sándor Switzerland	26	2.2k 2.5×	307 0.4×	1.0k 1.5×	205 0.4×	1.2k 2.7×	110	3.4k
Frode Willoch Norway	30	902 1.0×	1.5k 2.1×	1.7k 2.3×	495 1.0×	86 0.2×	55	3.7k
Hasan Herken Türkiye	32	1.4k 1.6×	380 0.5×	498 0.7×	317 0.7×	81 0.2×	119	3.4k
Gilbert Block United States	22	1.3k 1.5×	154 0.2×	970 1.4×	267 0.6×	713 1.6×	30	2.6k
Pauline Williams United Kingdom	16	393 0.5×	551 0.7×	379 0.5×	310 0.6×	133 0.3×	46	1.6k
Laura Bonanni Italy	39	1.1k 1.3×	1.3k 1.8×	808 1.1×	138 0.3×	146 0.3×	146	4.3k

Countries citing papers authored by Christopher R. Lines

Since Specialization

Citations

This map shows the geographic impact of Christopher R. Lines's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Christopher R. Lines with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Christopher R. Lines more than expected).

Fields of papers citing papers by Christopher R. Lines

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Christopher R. Lines. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Christopher R. Lines. The network helps show where Christopher R. Lines may publish in the future.

Co-authorship network of co-authors of Christopher R. Lines

This figure shows the co-authorship network connecting the top 25 collaborators of Christopher R. Lines. A scholar is included among the top collaborators of Christopher R. Lines based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Christopher R. Lines. Christopher R. Lines is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Herring, W. Joseph, Timothy E. Wilens, Lenard A. Adler, et al.. (2012). Randomized Controlled Study of the Histamine H3 Inverse Agonist MK-0249 in Adult Attention-Deficit/Hyperactivity Disorder. The Journal of Clinical Psychiatry. 73(7). e891–e898. 25 indexed citations

Morrison, Mary F., Paulette Ceesay, Ira Gantz, Keith D. Kaufman, & Christopher R. Lines. (2010). Randomized, controlled, double-blind trial of taranabant for smoking cessation. Psychopharmacology. 209(3). 245–253. 21 indexed citations

Shedden, Arthur, Ingrid Adamsons, Albert J. Getson, et al.. (2010). Comparison of the efficacy and tolerability of preservative-free and preservative-containing formulations of the dorzolamide/timolol fixed combination (COSOPT™) in patients with elevated intraocular pressure in a randomized clinical trial. Graefe s Archive for Clinical and Experimental Ophthalmology. 248(12). 1757–1764. 35 indexed citations

Sevigny, Jeffrey, Yahong Peng, Lian Liu, & Christopher R. Lines. (2009). Review: Item Analysis of ADAS-Cog: Effect of Baseline Cognitive Impairment in a Clinical AD Trial. American Journal of Alzheimer s Disease & Other Dementias®. 25(2). 119–124. 15 indexed citations

Liu, Kenneth S., Duane Snavely, William A. Ball, et al.. (2007). Is bigger better for depression trials?. Journal of Psychiatric Research. 42(8). 622–630. 16 indexed citations

Fechtner, Robert D., Kathleen McCarroll, Christopher R. Lines, & Ingrid Adamsons. (2005). Efficacy of the Dorzolamide/Timolol Fixed Combination Versus Latanoprost in the Treatment of Ocular Hypertension or Glaucoma: Combined Analysis of Pooled Data from Two Large Randomized Observer and Patient-Masked Studies. Journal of Ocular Pharmacology and Therapeutics. 21(3). 242–249. 14 indexed citations

Thal, Leon J., Steven H. Ferris, Louis Kirby, et al.. (2005). A Randomized, Double-Blind, Study of Rofecoxib in Patients with Mild Cognitive Impairment. Neuropsychopharmacology. 30(6). 1204–1215. 307 indexed citations

Brandes, Jan Lewis, W. Hester Visser, Mildred V. Farmer, et al.. (2004). Montelukast for Migraine Prophylaxis: A Randomized, Double‐Blind, Placebo‐Controlled Study. Headache The Journal of Head and Face Pain. 44(6). 581–586. 34 indexed citations

Reines, S., Gilbert Block, John C. Morris, et al.. (2004). Rofecoxib. Neurology. 62(1). 66–71. 285 indexed citations

10.

Fechtner, Robert D., et al.. (2003). Efficacy and tolerability of the dorzolamide 2%/timolol 0.5% combination (COSOPT™) versus latanoprost 0.005% (XALATAN™) in the treatment of ocular hypertension or glaucoma: results from two randomized clinical trials. Acta Ophthalmologica Scandinavica. 82(1). 42–48. 48 indexed citations

11.

Collantes‐Estévez, Eduardo, Sean Curtis, Ka Wing Lee, et al.. (2002). A multinational randomized, controlled, clinical trial of etoricoxib in the treatment of rheumatoid arthritis [ISRCTN25142273]. BMC Family Practice. 3(1). 10–10. 86 indexed citations

12.

Silberstein, Stephen D., H Massiou, Kathleen McCarroll, & Christopher R. Lines. (2002). Further Evaluation of Rizatriptan in Menstrual Migraine: Retrospective Analysis of Long‐term Data. Headache The Journal of Head and Face Pain. 42(9). 917–923. 40 indexed citations

13.

Lines, Christopher R., Kristel Vandormael, & William Malbecq. (2001). A comparison of visual analog scale and categorical ratings of headache pain in a randomized controlled clinical trial with migraine patients. Pain. 93(2). 185–190. 38 indexed citations

14.

Hawkey, C J, L. Jackson, S. E. Harper, et al.. (2001). The gastrointestinal safety profile of rofecoxib, a highly selective inhibitor of cyclooxygenase‐2, in humans. Alimentary Pharmacology & Therapeutics. 15(1). 1–9. 41 indexed citations

15.

Lines, Christopher R. & W. Hester Visser. (2001). Rizatriptan: Pharmacological Differences from Sumatriptan and Clinical Results. Current Medical Research and Opinion. 17(sup1). s54–58. 5 indexed citations

16.

Dahlöf, Carl, Alan M. Rapoport, Fred D. Sheftell, & Christopher R. Lines. (1999). Rizatriptan in the treatment of migraine. Clinical Therapeutics. 21(11). 1823–1836. 19 indexed citations

17.

Lines, Christopher R., et al.. (1991). The effects of pre-treatment with enalapril maleate on scopolamine-induced cognitive deficits in healthy volunteers. Journal of Psychopharmacology. 5(3). 228–233. 4 indexed citations

18.

Preston, G. C., C. Ward, Christopher R. Lines, et al.. (1989). Scopolamine and benzodiazepine models of dementia: cross-reversals by Ro 15-1788 and physostigmine. Psychopharmacology. 98(4). 487–494. 53 indexed citations

19.

Rugg, Michael D., et al.. (1987). Modulation of visual event-related potentials by spatial and non-spatial visual selective attention. Neuropsychologia. 25(1). 85–96. 127 indexed citations

20.

Rugg, Michael D., Christopher R. Lines, & A. David Milner. (1985). Further investigation of visual evoked potentials elicited by lateralized stimuli: Effects of stimulus eccentricity and reference site. Electroencephalography and Clinical Neurophysiology/Evoked Potentials Section. 62(2). 81–87. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact